Neurocrine Biosciences
$13.27 B
Share price
Change (1 day)
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Market capitalization of Neurocrine Biosciences (NBIX)

Market cap: $13.27 Billion

As of April 2024 Neurocrine Biosciences has a market cap of $13.27 Billion. This makes Neurocrine Biosciences the world's 1267th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Neurocrine Biosciences from 2001 to 2024

End of year Market Cap

Year Market cap Change
2024$13.27 B2.56%
2023$12.94 B12.74%
2022$11.48 B42.11%
2021$8.07 B-9.78%
2020$8.95 B-9.71%
2019$9.91 B52.97%
2018$6.48 B-5.57%
2017$6.86 B104.23%
2016$3.36 B-31.11%
2015$4.87 B185.67%
2014$1.70 B171.56%
2013$0.62 B26.57%
2012$0.49 B5.82%
2011$0.46 B12.02%
2010$0.41 B250.42%
2009$0.11 B-3.12%
2008$0.12 B-28.92%
2007$0.17 B-56.01%
2006$0.39 B-83.04%
2005$2.32 B29.33%
2004$1.80 B-6.48%
2003$1.92 B37.56%
2002$1.40 B-10.09%
2001$1.55 B

End of Day market cap according to different sources

On Apr 19th, 2024 the market cap of Neurocrine Biosciences was reported to be:

$13.27 Billion
by Yahoo Finance info icon info icon
$13.27 Billion
by CompaniesMarketCap info icon info icon
$13.13 Billion
by Nasdaq info icon info icon
$13.13 Billion
by Iex Cloud info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$147.22 B 1,008.92%๐Ÿ‡บ๐Ÿ‡ธ USA
$294.65 B 2,119.35%๐Ÿ‡บ๐Ÿ‡ธ USA
$690.55 B 5,101.28%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.77 B-33.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.83 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.37 B-89.65%๐Ÿ‡บ๐Ÿ‡ธ USA
$29.69 M-99.78%๐Ÿ‡บ๐Ÿ‡ธ USA
$16.82 B 26.72%๐Ÿ‡ฌ๐Ÿ‡ง UK